Table 2.

Follow-up features of the total patients and that between patients with balloon-mounted stenting and balloon predilation plus self-expanding stenting

Characteristic	Total patients		Patients treated with balloon-mounted stenting		Patients treated with balloon predilation plus self-expanding stenting		P Value
	n	Means (SD)/n (%)	n	Means (SD)/n (%)	n	Means (SD)/n (%)
Systolic blood pressure, mm Hg
Baseline	300	137.1 (16.76)	159	135.7 (15.05)	141	138.6 (18.33)	0.136
30 days	291	132.2 (11.99)	154	132.3 (13.40)	137	132.2 (10.21)	0.949
6 months	263	132.8 (10.52)	145	132.2 (10.58)	118	133.6 (10.42)	0.271
9 months	255	132.7 (10.17)	141	131.8 (9.95)	114	133.8 (10.38)	0.114
1 year	234	134.1 (13.42)	129	134.2 (12.77)	105	133.9 (14.24)	0.847
Low-density lipoprotein, mg/dL
Baseline	300	89.6 (36.61)	159	86.3 (37.28)	141	92.5 (35.27)	0.141
30 days	186	77.1 (26.35)	106	77.0 (25.62)	80	77.2 (27.45)	0.965
1 year	89	80.4 (37.27)	46	78.4 (39.38)	43	82.6 (35.20)	0.602
BMI
Baseline	300	25.6 (3.02)	159	25.7 (3.14)	141	25.5 (2.88)	0.669
1 year	251	25.7 (3.07)	139	25.8 (3.02)	122	25.5 (3.15)	0.483
Re-stenosis features	76		40		36
Degree of re-stenosis, %		30.4 (34.16)		35.7 (36.26)		24.5 (31.13)	0.157
Restenosis ≥50%		21 (27.6%)		11 (27.5%)		10 (27.7%)	1.000
Restenosis ≥70%		14 (18.4%)		10 (25.0%)		4 (11.1%)	0.146

BMI, body mass index.